You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotoxin

Showing 1 - 25 of 108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

Completed
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 28, 2022

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, ipilimumab)

Recruiting
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National

Not yet recruiting
  • Malignant Pleural Mesotheliomas (Mpm)
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

Active, not recruiting
Has Results
  • Hairy Cell Leukemia
  • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022

Mesothelioma Trial run by the NCI (LMB-100, Pembrolizumab)

Terminated
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 3, 2021

Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,

Active, not recruiting
Has Results
  • Neoplasms With Mesothelin Expression
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 18, 2022

Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)

Completed
Has Results
  • Neoplasms
  • Pancreatic Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 16, 2022

Colorectal Cancer Metastatic Trial in Oslo (BM7PE)

Unknown status
  • Colorectal Cancer Metastatic
  • Oslo, Norway
    Oslo University Hospital
Feb 16, 2021

Acute Lymphoblastic Leukemia Treated With Anti-CD22

Recruiting
  • Acute Lymphoblastic Leukemia
  • Anti-CD22 Immunotoxin
  • Meldola (FC), FC, Italy
  • +4 more
Feb 25, 2021

Bladder Cancer, Breast Cancer, Colorectal Cancer Trial in Baltimore, Bethesda (LMB-9 immunotoxin)

Completed
  • Bladder Cancer
  • +5 more
  • LMB-9 immunotoxin
  • Baltimore, Maryland
  • +1 more
Oct 31, 2019

Steroid-Refractory Acute GVHD Trial in United States (T-Guard)

Terminated
Has Results
  • Steroid-Refractory Acute Graft Versus Host Disease
  • Duarte, California
  • +23 more
Dec 7, 2021

Mesothelioma Trial run by the NCI (LMB-100, SEL-110)

Terminated
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 4, 2019

Refractory B-Lineage Leukemia, Relapsed B-Lineage Leukemia, Refractory B-Lineage Lymphoma Trial in Minneapolis (DT2219ARL)

Completed
Has Results
  • Refractory B-Lineage Leukemia
  • +3 more
  • DT2219ARL
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 27, 2019

Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

Active, not recruiting
  • Hairy Cell Leukemia
  • Moxetumomab Pasudotox-tdfk
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)

Active, not recruiting
  • Malignant Glioma
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    Preston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022

Adult B Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia Trial in Bronx, Philadelphia (drug,

Terminated
  • Adult B Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Bronx, New York
  • +1 more
Sep 4, 2019

Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in United States (Glembatumumab Vedotin, Laboratory Biomarker

Completed
Has Results
  • Recurrent Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • Glembatumumab Vedotin
  • +2 more
  • Phoenix, Arizona
  • +24 more
Jul 30, 2020

Lymphoma Trial in Dallas (RFT5-dgA immunotoxin, fluorescence activated cell sorting, immunohistochemistry staining method)

Terminated
Has Results
  • Lymphoma
  • RFT5-dgA immunotoxin
  • +2 more
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Nov 21, 2018

Pancreatic Cancer Trial in Shatin (MSLN CART)

Not yet recruiting
  • Pancreatic Cancer
  • MSLN CART
  • Shatin, N.t., Hong Kong
    Endoscopy Centre, Prince of Wales Hospital
Sep 19, 2023

DLBCL, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Minneapolis (E7777)

Recruiting
  • DLBCL
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Jul 1, 2022

Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

Recruiting
  • Hairy Cell Leukemia
  • Hairy Cell Leukemia Variant
  • CD22CART cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

T-Cell Lymphocytic Leukemia, T-Cell Chronic Lymphocytic Leukemia, T Cell Non-Hodgkin Lymphoma Trial in Wuhan (Fludarabine +

Recruiting
  • T-Cell Lymphocytic Leukemia
  • +2 more
  • Fludarabine + Cyclophosphamide + CAR7-T Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
Mar 1, 2022

Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)

Active, not recruiting
Has Results
  • Adult T-Cell Leukemia (ATL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 13, 2022

Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA Trial in United States (milatuzumab)

Completed
  • Multiple Myeloma
  • +2 more
  • milatuzumab
  • Atlanta, Georgia
  • +5 more
Aug 12, 2021

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023